Table 2.
The influence of variables on survival parameters.
| Analyzed Parameter | RFS | PFS 1 | PFS 2 | OS | ||||
|---|---|---|---|---|---|---|---|---|
| Test Value | p | Test Value | p | Test Value | p | Test Value | p | |
| Sex | 1.058 | 0.289 | 1.815 | 0.069 | 1.726 | 0.084 | 0.720 | 0.471 |
| Age | 0.076 | 0.782 | 0.187 | 0.664 | 0.506 | 0.476 | 0.708 | 0.400 |
| Type of recurrence | 0.837 | 0.402 | −0.409 | 0.682 | 0.055 | 0.955 | 1.740 | 0.081 |
| Location of primary lesion | −0.208 | 0.835 | 0.274 | 0.7831 | −0.382 | 0.701 | 0.134 | 0.892 |
| BRAF status | −2.211 | 0.027 | 1.266 | 0.205 | 0.546 | 0.584 | −0.530 | 0.595 |
| HGB (<12.5 vs. ≥12.5 g/dL) | −0.265 | 0.790 | −1.312 | 0.189 | −1.553 | 0.120 | −1.415 | 0.157 |
| MCV (norm vs. beyond the norm) | 1.224 | 0.542 | 0.624 | 0.731 | 1.280 | 0.527 | 0.534 | 0.765 |
| MCH (norm vs. beyond the norm) | 0.245 | 0.884 | 1.566 | 0.457 | 5.065 | 0.079 | 0.587 | 0.745 |
| MCHC (norm vs. beyond the norm) | −0.456 | 0.648 | −1.132 | 0.257 | −0.701 | 0.482 | −0.804 | 0.421 |
| PLT (norm vs. beyond the norm) | 0.771 | 0.440 | −0.833 | 0.404 | −0.354 | 0.722 | −0.283 | 0.776 |
| LDH (continuous value) | 0.128 | 0.719 | 1.582 | 0.208 | 2.051 | 0.152 | 1.946 | 0.162 |
| Primary surgical treatment | −1.630 | 0.103 | 0.182 | 0.856 | −0.741 | 0.458 | −0.748 | 0.454 |
| Level of invasion (Clark classification) | 4.977 | 0.418 | 2.447 | 0.784 | NA | NA | 3.322 | 0.650 |
| Type of treatment (anti-BRAF vs. immunotherapy) | NA * | NA | 1.998 | 0.046 | NA | NA | 0.238 | 0.812 |
| Lung metastases | NA | NA | NA | NA | NA | NA | 0.521 | 0.602 |
| Liver metastases | NA | NA | NA | NA | NA | NA | 0.176 | 0.860 |
| Brain metastases | NA | NA | NA | NA | NA | NA | 0.344 | 0.730 |
| Lymph node metastases | NA | NA | NA | NA | NA | NA | −0.389 | 0.697 |
| Skin and subcutaneous tissue metastases | NA | NA | NA | NA | NA | NA | −0.003 | 0.997 |
| Bone metastases | NA | NA | NA | NA | NA | NA | 0.224 | 0.823 |
| Other | NA | NA | NA | NA | NA | NA | −0.024 | 0.980 |
* NA (not applicable)—Thetest cannot be performed due to the small number of complete observations.